Independent Clinical Studies

View independent clinical outcomes from hospitals that have implemented Nozin® NOVA℠ infection prevention programs.

Facilities have achieved results like these:

96% MRSA infection rate reduction

100% MRSA SSI reduction

74% Decline in MRSA bacteremia


Take the first step to reduce HAI rates in your facility

What to expect from your complimentary assessment:

  • A comprehensive report detailing your facility's current colonization risk profile
  • Analysis of the impact of colonization risk on patients, staff, and facility operations
  • Specific recommendations for addressing risk and meeting infection prevention goals

Additional references at:

Health Professionals:
Request a comprehensive analysis of your colonization risk mitigation protocols today.

© 2004-2023 Global Life Technologies Corp. All rights reserved. All trademarks are property of their respective owners. Nozin® Nasal Sanitizer® antiseptic is an OTC topical antiseptic drug and no claim is made that it has an effect on any specific disease. | Patent Nos.